Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: +0.15% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 3 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -31%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 3 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~3.2% on $6M of debt.
Cash of $1M is below short-term debt of $6M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $24.9M 100.0% | $18.9M 100.0% | $21.1M 100.0% |
| Cost of Revenue | $17.2M 69.1% | $13.2M 70.0% | $14.4M 68.0% |
| Gross Profit | $7.7M 30.9% | $5.7M 30.0% | $6.8M 32.0% |
| Research & Development | $3.3M 13.1% | $1.7M 8.9% | $1.4M 6.5% |
| Selling, General & Admin | $6.8M 27.3% | $544K 2.9% | $579K 2.7% |
| Total Operating Expenses | $10.8M 43.4% | $2.9M 15.2% | $3.1M 14.8% |
| Operating Income | -$3.1M -12.5% | $2.8M 14.8% | $3.6M 17.2% |
| Interest Expense | $183K 0.7% | $121K 0.6% | $53K 0.2% |
| Other Income (Expense), net | -$2.9M -11.5% | -$81K -0.4% | $543K 2.6% |
| Pretax Income | -$6.0M -24.0% | $2.7M 14.4% | $4.2M 19.7% |
| Income Tax Expense | -$270K -1.1% | $276K 1.5% | $715K 3.4% |
| Net Income | -$5.7M -22.9% | $2.4M 12.9% | $3.5M 16.4% |
| Per Share | |||
| EPS (Basic) | $-0.53 | $0.24 | $0.35 |
| EPS (Diluted) | $-0.53 | $0.24 | $0.35 |
| Weighted Avg Shares (Basic) | 10.7M | 10.0M | 10.0M |
| Weighted Avg Shares (Diluted) | 10.7M | 10.0M | 10.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$3M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 243 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EC | $673.9B | — | — | — | — | — | — | — | — | — | 154 |
| XOM | $633.7B | 22.6× | — | 1.9× | -5.0% | — | 8.7% | 11.1% | 10.7% | — | 4,568 |
| CVX | $344.7B | 28.1× | — | 1.8× | -6.8% | 42.8% | 6.5% | 6.6% | 6.6% | — | 4,121 |
| RYDAF | $253.5B | — | — | — | — | — | — | — | — | — | 5 |
| TTE | $187.0B | — | — | — | — | — | — | — | — | — | 951 |
| COP | $144.0B | 18.1× | — | 2.4× | 7.7% | 62.1% | 13.6% | 12.4% | 12.2% | — | 2,450 |
| STOHF | $99.4B | — | — | — | — | — | — | — | — | — | 3 |
| VLO | $93.4B | 40.0× | 17.9× | 0.8× | -5.5% | 4.4% | 1.9% | 9.9% | 7.1% | 1.7× | 1,781 |
| CNQ | $93.2B | — | — | — | — | — | — | — | — | — | 709 |
| MPC | $90.8B | 22.5× | 7.8× | 0.7× | -4.4% | 10.0% | 3.0% | 23.4% | 20.6% | 0.2× | 1,802 |
| WMB | $87.7B | 33.6× | 17.8× | 7.3× | 13.8% | — | 21.9% | 20.4% | 6.3% | 4.4× | 1,736 |
| EIPAF | $84.0B | — | — | — | — | — | — | — | — | — | 2 |
| PSX | $82.2B | 18.8× | — | 0.6× | -7.5% | 12.3% | 3.3% | 15.1% | 8.9% | — | 2,041 |
| SU | $75.0B | — | — | — | — | — | — | — | — | — | 724 |
| SLB | $74.6B | 21.2× | — | 2.1× | -1.6% | — | 9.4% | 12.9% | 9.4% | — | 1,624 |
| EOG | $72.9B | 14.7× | 7.1× | 3.2× | -4.5% | — | 22.0% | 16.7% | 13.2% | 0.7× | 1,525 |
| BKR | $61.2B | — | — | 2.2× | -0.3% | — | 9.3% | 13.7% | 10.1% | — | 1,095 |
| IMO | $60.7B | 19.3× | — | 1.3× | -8.6% | — | 6.9% | 14.7% | 12.7% | — | 394 |
| LNG | $56.0B | 10.6× | 7.4× | 2.8× | 27.2% | — | 34.0% | 85.8% | 22.1% | 2.2× | 1,303 |
| TRGP | $55.8B | 30.6× | 15.1× | 3.3× | 3.9% | 38.3% | 11.3% | 62.7% | 9.4% | 3.6× | 979 |
| OKE | $54.9B | 16.1× | 11.9× | 1.6× | 55.0% | 30.5% | 10.1% | 15.1% | 6.3% | 4.4× | 1,622 |
| FANG | $53.0B | 32.5× | 10.7× | 3.5× | 35.8% | — | 10.3% | 4.2% | 3.0% | 2.3× | 1,141 |
| CVE | $52.2B | — | — | — | — | — | — | — | — | — | 437 |
| WOPEF | $42.7B | — | — | — | — | — | — | — | — | — | 3 |
| CCJ | $41.1B | — | — | — | — | — | — | — | — | — | 970 |
| STAK | $25M | — | — | 1.0× | 31.7% | 30.9% | -22.9% | -44.3% | -30.8% | -2.0× | 5 |
Peers = companies sharing STAK's sector (Energy) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 5 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-08-05
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cost of Revenue | 68.0 | 70.0 | 69.1 |
| Gross Profit | 32.0 | 30.0 | 30.9 |
| R&D | 6.5 | 8.9 | 13.1 |
| SG&A | 2.7 | 2.9 | 27.3 |
| Operating Income | 17.2 | 14.8 | -12.5 |
| Income Tax | 3.4 | 1.5 | -1.1 |
| Net Income | 16.4 | 12.9 | -22.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on STAK: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.